| Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study RL Carhart-Harris, M Bolstridge, J Rucker, CMJ Day, D Erritzoe, M Kaelen, ... The Lancet Psychiatry 3 (7), 619-627, 2016 | 1553 | 2016 |
| Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ... American Journal of Psychiatry 174 (3), 216-229, 2017 | 951 | 2017 |
| Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review ND Volkow, JM Swanson, AE Evins, LE DeLisi, MH Meier, R Gonzalez, ... JAMA psychiatry 73 (3), 292-297, 2016 | 937 | 2016 |
| Psilocybin with psychological support for treatment-resistant depression: six-month follow-up RL Carhart-Harris, M Bolstridge, CMJ Day, J Rucker, R Watts, DE Erritzoe, ... Psychopharmacology 235, 399-408, 2018 | 928 | 2018 |
| Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [11C]PBR28 PET Brain Imaging Study PS Bloomfield, S Selvaraj, M Veronese, G Rizzo, A Bertoldo, DR Owen, ... American Journal of Psychiatry 173 (1), 44-52, 2016 | 475 | 2016 |
| The effects of Δ9-tetrahydrocannabinol on the dopamine system MAP Bloomfield, AH Ashok, ND Volkow, OD Howes Nature 539 (7629), 369-377, 2016 | 388 | 2016 |
| Experiences of frontline healthcare workers and their views about support during COVID-19 and previous pandemics: a systematic review and qualitative meta-synthesis J Billings, BCF Ching, V Gkofa, T Greene, M Bloomfield BMC health services research 21, 1-17, 2021 | 358 | 2021 |
| Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort A Egerton, CA Chaddock, TT Winton-Brown, MAP Bloomfield, ... Biological psychiatry 74 (2), 106-112, 2013 | 293 | 2013 |
| Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms MAP Bloomfield, CJA Morgan, A Egerton, S Kapur, HV Curran, OD Howes Biological psychiatry 75 (6), 470-478, 2014 | 262 | 2014 |
| Medicinal use of cannabis based products and cannabinoids TP Freeman, C Hindocha, SF Green, MAP Bloomfield Bmj 365, 2019 | 244 | 2019 |
| Treatment-resistant schizophrenia patients show elevated anterior cingulate cortex glutamate compared to treatment-responsive E Mouchlianitis, MAP Bloomfield, V Law, K Beck, S Selvaraj, N Rasquinha, ... Schizophrenia bulletin 42 (3), 744-752, 2016 | 241 | 2016 |
| The neuropsychopharmacology of cannabis: A review of human imaging studies MAP Bloomfield, C Hindocha, SF Green, MB Wall, R Lees, K Petrilli, ... Pharmacology & therapeutics 195, 132-161, 2019 | 234 | 2019 |
| Predictors and rates of PTSD, depression and anxiety in UK frontline health and social care workers during COVID-19 T Greene, J Harju-Seppänen, M Adeniji, C Steel, N Grey, CR Brewin, ... European Journal of Psychotraumatology 12 (1), 1882781, 2021 | 176 | 2021 |
| Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial TP Freeman, C Hindocha, G Baio, NDC Shaban, EM Thomas, D Astbury, ... The Lancet Psychiatry 7 (10), 865-874, 2020 | 175 | 2020 |
| The effects of acutely administered 3, 4-methylenedioxymethamphetamine on spontaneous brain function in healthy volunteers measured with arterial spin labeling and blood oxygen … RL Carhart-Harris, K Murphy, R Leech, D Erritzoe, MB Wall, B Ferguson, ... Biological psychiatry 78 (8), 554-562, 2015 | 172 | 2015 |
| Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis ‘amotivational’hypotheses W Lawn, TP Freeman, RA Pope, A Joye, L Harvey, C Hindocha, ... Psychopharmacology 233, 3537-3552, 2016 | 149 | 2016 |
| The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories RL Carhart-Harris, MB Wall, D Erritzoe, M Kaelen, B Ferguson, I De Meer, ... International Journal of Neuropsychopharmacology 17 (4), 527-540, 2014 | 135 | 2014 |
| Supporting hospital staff during COVID-19: early interventions J Billings, T Greene, T Kember, N Grey, S El-Leithy, D Lee, H Kennerley, ... Occupational Medicine 70 (5), 327-329, 2020 | 119* | 2020 |
| The effects of psychosocial stress on dopaminergic function and the acute stress response MAP Bloomfield, RA McCutcheon, M Kempton, TP Freeman, O Howes Elife 8, e46797, 2019 | 115 | 2019 |
| Adversity in childhood linked to elevated striatal dopamine function in adulthood A Egerton, LR Valmaggia, OD Howes, F Day, CA Chaddock, P Allen, ... Schizophrenia research 176 (2-3), 171-176, 2016 | 111 | 2016 |
